Cargando…

Potential and Limits of Cannabinoids in Alzheimer’s Disease Therapy

SIMPLE SUMMARY: This review was aimed at exploring the potentiality of drugging the endocannabinoid system as a therapeutic option for Alzheimer’s disease (AD). Recent discoveries have demonstrated how the modulation of cannabinoid receptor 1 (CB1) and receptor 2 (CB2) can exert neuroprotective effe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abate, Giulia, Uberti, Daniela, Tambaro, Simone
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234911/ https://www.ncbi.nlm.nih.gov/pubmed/34204237 http://dx.doi.org/10.3390/biology10060542

Ejemplares similares

Nutrition and AGE-ing: Focusing on Alzheimer's Disease
por: Abate, Giulia, et al.
Publicado: (2017)

Impact of COVID-19 on Alzheimer’s Disease Risk: Viewpoint for Research Action
por: Abate, Giulia, et al.
Publicado: (2020)

The pleiotropic role of p53 in functional/dysfunctional neurons: focus on pathogenesis and diagnosis of Alzheimer’s disease
por: Abate, Giulia, et al.
Publicado: (2020)

Post-translational Modifications of the p53 Protein and the Impact in Alzheimer’s Disease: A Review of the Literature
por: Clark, James S., et al.
Publicado: (2022)

A telescope GWAS analysis strategy, based on SNPs-genes-pathways ensamble and on multivariate algorithms, to characterize late onset Alzheimer’s disease
por: Squillario, Margherita, et al.
Publicado: (2020)

Impact of the Cannabinoid System in Alzheimer's Disease
por: Li, Shuangtao, et al.
Publicado: (2023)

CB(2) Cannabinoid Receptor As Potential Target against Alzheimer's Disease
por: Aso, Ester, et al.
Publicado: (2016)

Translational potential of synaptic alterations in Alzheimer’s disease patients and amyloid precursor protein knock-in mice
por: Medina-Vera, Dina, et al.
Publicado: (2023)

Cannabinoids as a Potential Alternative to Opioids in the Management of Various Pain Subtypes: Benefits, Limitations, and Risks
por: Ang, Samuel P., et al.
Publicado: (2023)

Neural Stem Cells and Cannabinoids in the Spotlight as Potential Therapy for Epilepsy
por: Lourenço, Diogo M., et al.
Publicado: (2020)

Unfolded p53 in the pathogenesis of Alzheimer's disease: is HIPK2 the link?
por: Stanga, Serena, et al.
Publicado: (2010)

Cannabinoid Receptors Are Overexpressed in CLL but of Limited Potential for Therapeutic Exploitation
por: Freund, Patricia, et al.
Publicado: (2016)

Therapeutic Potential of Cannabinoids in Glaucoma
por: Lindner, Theresa, et al.
Publicado: (2023)

Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic
por: Aso, Ester, et al.
Publicado: (2014)

Cannabinoid pharmacology and its therapeutic uses in Alzheimer’s disease
por: Monteiro, Kadja Luana Chagas, et al.
Publicado: (2020)

Cannabinoid-Based Ocular Therapies and Formulations
por: Saraiva, Sofia M., et al.
Publicado: (2023)

A Conformation Variant of p53 Combined with Machine Learning Identifies Alzheimer Disease in Preclinical and Prodromal Stages
por: Abate, Giulia, et al.
Publicado: (2020)

Therapeutic properties of multi-cannabinoid treatment strategies for Alzheimer’s disease
por: Coles, Madilyn, et al.
Publicado: (2022)

Cannabinoids in Parkinson's Disease
por: Stampanoni Bassi, Mario, et al.
Publicado: (2017)

Alzheimer’s Disease: Treatment Strategies and Their Limitations
por: Passeri, Elodie, et al.
Publicado: (2022)

Mechanistic Potential and Therapeutic Implications of Cannabinoids in Nonalcoholic Fatty Liver Disease
por: Dibba, Pratima, et al.
Publicado: (2018)

Therapeutic Potential of Minor Cannabinoids in Dermatological Diseases—A Synthetic Review
por: Kwiecień, Emilia, et al.
Publicado: (2023)

The Pathophysiology and the Therapeutic Potential of Cannabinoids in Prostate Cancer
por: Singh, Kanika, et al.
Publicado: (2021)

Cannabinoids—Characteristics and Potential for Use in Food Production
por: Kanabus, Joanna, et al.
Publicado: (2021)

Cannabinoids and Chronic Liver Diseases
por: Mboumba Bouassa, Ralph-Sydney, et al.
Publicado: (2022)

Cannabinoid Signaling in Kidney Disease
por: Arceri, Liana, et al.
Publicado: (2023)

Cannabinoids and Their Receptors in Skin Diseases
por: Yoo, Eun Hee, et al.
Publicado: (2023)

Gene therapy in Alzheimer’s disease – potential for disease modification
por: Nilsson, Per, et al.
Publicado: (2010)

Promising cannabinoid-based therapies for Parkinson’s disease: motor symptoms to neuroprotection
por: More, Sandeep Vasant, et al.
Publicado: (2015)

Future Aspects for Cannabinoids in Breast Cancer Therapy
por: Kisková, Terézia, et al.
Publicado: (2019)

Cannabinoids for clinicians: the rise and fall of the cannabinoid antagonists
por: Butler, Helen, et al.
Publicado: (2009)

Cannabinoids and Cannabinoid Receptors: The Story so Far
por: Shahbazi, Fred, et al.
Publicado: (2020)

Aerosol Jet Printed 3D Electrochemical Sensors for Protein Detection
por: Cantù, Edoardo, et al.
Publicado: (2018)

Cannabis, Cannabinoids, and the Endocannabinoid System—Is there Therapeutic Potential for Inflammatory Bowel Disease?
por: Ambrose, Tim, et al.
Publicado: (2019)

Cannabinoid CB(2) receptors in the mouse brain: relevance for Alzheimer’s disease
por: López, Alicia, et al.
Publicado: (2018)

Modulation of the Cannabinoid System: A New Perspective for the Treatment of the Alzheimer’s Disease
por: Giuseppina, Talarico, et al.
Publicado: (2019)

Targeting the cannabinoid system to counteract the deleterious effects of stress in Alzheimer’s disease
por: Shade, Ronnie D., et al.
Publicado: (2022)

Potential Use of Cannabinoids for the Treatment of Pancreatic Cancer
por: Sharafi, Golnaz, et al.
Publicado: (2019)

Critical appraisal of the potential use of cannabinoids in cancer management
por: Cridge, Belinda J, et al.
Publicado: (2013)

Exploring the Potential of Cannabinoid Nanodelivery Systems for CNS Disorders
por: Kolesarova, Mariana, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mf2m2mqbqof028hg8552v7sf3b